Journal
NUCLEIC ACIDS RESEARCH
Volume 40, Issue D1, Pages D947-D956Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkr881
Keywords
-
Categories
Funding
- Cancer Research UK [C309/A8274]
- NHS
- Cancer Research UK [11566] Funding Source: researchfish
Ask authors/readers for more resources
canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available